BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gayral M, Jo S, Hanoun N, Vignolle-Vidoni A, Lulka H, Delpu Y, Meulle A, Dufresne M, Humeau M, Rieu MCD, Bournet B, Sèlves J, Guimbaud R, Carrère N, Buscail L, Torrisani J, Cordelier P. MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer. World J Gastroenterol 2014; 20(32): 11199-11209 [PMID: 25170204 DOI: 10.3748/wjg.v20.i32.11199]
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11199.htm
Number Citing Articles
1
Vishal Chandra, Jong Joo Kim, Balraj Mittal, Rajani Rai. MicroRNA aberrations: An emerging field for gallbladder cancer managementWorld Journal of Gastroenterology 2016; 22(5): 1787-1799 doi: 10.3748/wjg.v22.i5.1787
2
Wei Yuan, Wanyan Tang, Yibin Xie, Shaoming Wang, Yingtai Chen, Jun Qi, Youlin Qiao, Jie Ma. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancerOncotarget 2016; 7(48): 80033 doi: 10.18632/oncotarget.12406
3
Frank C. Passero, Muhammad Wasif Saif. Second line treatment options for pancreatic cancerExpert Opinion on Pharmacotherapy 2017; 18(15): 1607 doi: 10.1080/14656566.2017.1369955
4
Aoife S Crawley, Richard J O’Kennedy. The need for effective pancreatic cancer detection and management: a biomarker-based strategyExpert Review of Molecular Diagnostics 2015; 15(10): 1339 doi: 10.1586/14737159.2015.1083862
5
Louis Buscail, Barbara Bournet, Marlène Dufresne, Jérôme Torrisani, Pierre Cordelier. Nouveautés dans la biologie du cancer du pancréasBulletin du Cancer 2015; 102(6): S53 doi: 10.1016/S0007-4551(15)31218-2
6
Barbara Bournet, Camille Buscail, Fabrice Muscari, Pierre Cordelier, Louis Buscail. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realitiesEuropean Journal of Cancer 2016; 54: 75 doi: 10.1016/j.ejca.2015.11.012
7
Muhammed Bekmezci, Ramazan Bayat, Merve Akin, Zeynep Kazel Coguplugil, Fatih Sen. Modified screen-printed electrochemical biosensor design compatible with mobile phones for detection of miR-141 used to pancreatic cancer biomarkerCarbon Letters 2023; 33(6): 1863 doi: 10.1007/s42823-023-00545-9
8
Maria Braoudaki, George I Lambrou, Krinio Giannikou, Vasilis Milionis, Kalliopi Stefanaki, Diane K Birks, Neophytos Prodromou, Aggeliki Kolialexi, Antonis Kattamis, Chara A Spiliopoulou, Fotini Tzortzatou-Stathopoulou, Emmanouel Kanavakis. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasmsJournal of Hematology & Oncology 2014; 7(1) doi: 10.1186/s13045-014-0096-y
9
Bhupendra S. Kaphalia. Biomarkers in Toxicology2019; : 341 doi: 10.1016/B978-0-12-814655-2.00019-0
10
Přemysl Frič, Jan Škrha, Aleksi Šedo, Tomaš Zima, Petr Bušek, Klára Kmochová, Martin Laclav, Bohuš Bunganič, Svatopluk Solař, Petr Hrabal, František Bělina, Pavel Záruba, Pavel Škrha, Miroslav Zavoral. Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkersEuropean Journal of Gastroenterology & Hepatology 2016; 28(12): e33 doi: 10.1097/MEG.0000000000000727
11
Chengjin Zhao, Na Ban, Shirong Dai, Xiubing Zhang, Li Zhang, Peng Xu, Wenjuan Chen, Jie Sun, Zhen Bao, Hao Chang, Donglin Wang, Jianbing Ren. The role of Alix in the proliferation of human glioma cellsHuman Pathology 2016; 52: 110 doi: 10.1016/j.humpath.2015.09.046
12
Wei-Zhong Sheng, Yu-Sheng Chen, Chuan-Tao Tu, Juan He, Bo Zhang, Wei-Dong Gao. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancerWorld Journal of Gastroenterology 2016; 22(24): 5532-5539 doi: 10.3748/wjg.v22.i24.5532
13
Suresh Sulekha Dhanisha, Chandrasekharan Guruvayoorappan, Sudarsanan Drishya, Prathapan Abeesh. Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targetsCritical Reviews in Oncology/Hematology 2018; 122: 98 doi: 10.1016/j.critrevonc.2017.12.006
14
Haiyan Jia, Hong Wang, Yanfen Yao, Chunlei Wang, Pibao Li. miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(6): 967 doi: 10.3727/096504018X15148192843443
15
Maria Mortoglou, Aleksandra Buha Djordjevic, Vladimir Djordjevic, Hunter Collins, Lauren York, Katherine Mani, Elizabeth Valle, David Wallace, Pinar Uysal-Onganer. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinomaArchives of Toxicology 2022; 96(2): 467 doi: 10.1007/s00204-021-03196-9
16
Ulrike Erb, Margot Zöller. Progress and potential of exosome analysis for early pancreatic cancer detectionExpert Review of Molecular Diagnostics 2016; 16(7): 757 doi: 10.1080/14737159.2016.1187563
17
Sameer Dhayat, Max Traeger, Jan Rehkaemper, Anda Stroese, Konrad Steinestel, Eva Wardelmann, Iyad Kabar, Norbert Senninger. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal AdenocarcinomaCancers 2018; 10(9): 328 doi: 10.3390/cancers10090328
18
Georges Vassaux, Assia Angelova, Patrick Baril, Patrick Midoux, Jean Rommelaere, Pierre Cordelier. The Promise of Gene Therapy for Pancreatic CancerHuman Gene Therapy 2016; 27(2): 127 doi: 10.1089/hum.2015.141
19
Sachin Wani, V. Raman Muthusamy, Cindy M. McGrath, Antonia R. Sepulveda, Ananya Das, Wells Messersmith, Michael L. Kochman, Janak Shah. AGA White Paper: Optimizing Endoscopic Ultrasound–Guided Tissue Acquisition and Future DirectionsClinical Gastroenterology and Hepatology 2018; 16(3): 318 doi: 10.1016/j.cgh.2017.10.020
20
Yiwen Yu, Ying Tong, Ailing Zhong, Yanchun Wang, Renquan Lu, Lin Guo. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancerMedicine 2020; 99(52): e23863 doi: 10.1097/MD.0000000000023863
21
Saurabh S. Mukewar, V. Raman Muthusamy. Future directions in endoscopic ultrasound-guided tissue acquisitionTechniques in Gastrointestinal Endoscopy 2018; 20(1): 46 doi: 10.1016/j.tgie.2017.11.004
22
Pavel Škrha, Aleš Hořínek, Eva Pazourková, Jan Hajer, Přemysl Frič, Jan Škrha, Michal Anděl. Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitusPancreatology 2016; 16(5): 839 doi: 10.1016/j.pan.2016.05.005
23
Yinghao Lv, Shuai Huang. Role of non‑coding RNA in pancreatic cancer (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.10758
24
Jae Keun Park, Kwang Hyuck Lee. Present and Future of Endoscopic Ultrasound-Guided Tissue Acquisition in Solid Pancreatic TumorsClinical Endoscopy 2019; 52(6): 541 doi: 10.5946/ce.2019.127
25
Guo Liang Han, Jian Wang, Kang Guo, Jia Kuan Chen, Rong Xin Shang, Tao Jiang. miRNA-574-5p downregulates ZNF70 and influences the progression of human esophageal squamous cell carcinoma through reactive oxygen species generation and MAPK pathway activationAnti-Cancer Drugs 2020; 31(3): 282 doi: 10.1097/CAD.0000000000000833
26
Neveen Abd El Moneim Hussein, Zenat A. El Kholy, Medhat M. Anwar, Mohamed A. Ahmad, Shaymaa M. Ahmad. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancerJournal of Cancer Research and Clinical Oncology 2017; 143(1): 83 doi: 10.1007/s00432-016-2248-7
27
Nicolas Jonckheere, Romain Vasseur, Isabelle Van Seuningen. The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targetingCritical Reviews in Oncology/Hematology 2017; 111: 7 doi: 10.1016/j.critrevonc.2017.01.002
28
Yuan Yu, Lei Liu, Ruirui Ma, Haibing Gong, Ping Xu, Congjun Wang. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancerTumor Biology 2016; 37(10): 14249 doi: 10.1007/s13277-016-5270-0
29
Deying Yang, Yutao Li, Deqin Zhao. Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathwayOncology Letters 2017; 14(2): 1811 doi: 10.3892/ol.2017.6321
30
Jian Zhang, Yi-Guo Yan, Cheng Wang, Shu-Jun Zhang, Xiao-Hua Yu, Wen-Jun Wang. MicroRNAs in osteosarcomaClinica Chimica Acta 2015; 444: 9 doi: 10.1016/j.cca.2015.01.025
31
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
32
Louis Buscail, Barbara Bournet, Pierre Cordelier. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancerNature Reviews Gastroenterology & Hepatology 2020; 17(3): 153 doi: 10.1038/s41575-019-0245-4
33
Yushuang Luo, Chengwu Zhang, Feng Tang, Junhui Zhao, Cunfang Shen, Cheng Wang, Pengjie Yu, Miaozhou Wang, Yan Li, J. I. Di, Rong Chen, Ge Rili. Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profilingCancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0266-1
34
L. Buscail, B. Bournet. Quoi de neuf en recherche fondamentale et translationnelle sur le cancer du pancréas ?Oncologie 2015; 17(11-12): 535 doi: 10.1007/s10269-015-2569-1